Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J S Larsen

Showing results (41-50 of 50) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 50 results.
The Journal of Asthma : Official Journal of the Association for the Care of Asthma|January 1, 1991
Sensitivity of FEV1 response following one and two inhalations of albuterol: a pilot studyS N Quessy, R J Morris, J S Larsen, et al.
Environmental Science & Technology|March 31, 2006
Impairment of cellular immunity in west Greenland sledge dogs (Canis familiaris) dietary exposed to polluted minke whale (Balaenoptera acutorostrata) blubberChristian Sonne, Rune Dietz, Hans J S Larsen, et al.
Animal : an International Journal of Animal Bioscience|March 27, 2012
Effects of housing conditions during the rearing and laying period on adrenal reactivity, immune response and heterophil to lymphocyte (H/L) ratios in laying hensR O Moe, D Guémené, M Bakken, et al.
Biochemical Pharmacology|December 28, 2014
GABAA α5 subunit-containing receptors do not contribute to reversal of inflammatory-induced spinal sensitization as indicated by the unique selectivity profile of the GABAA receptor allosteric modulator NS16085A Garcia de Lucas, P K Ahring, J S Larsen, et al.
Annals of Allergy|August 1, 1993
Administration errors with a conventional metered dose inhaler versus a novel breath actuated deviceJ S Larsen, M Hahn, J W Kochevar, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 16, 2008
Comparison of the novel subtype-selective GABAA receptor-positive allosteric modulator NS11394 [3'-[5-(1-hydroxy-1-methyl-ethyl)-benzoimidazol-1-yl]-biphenyl-2-carbonitrile] with diazepam, zolpidem, bretazenil, and gaboxadol in rat models of inflammatory and neuropathic painG Munro, J A Lopez-Garcia, I Rivera-Arconada, et al.
Journal of Aerosol Medicine : the Official Journal of the International Society for Aerosols in Medicine|February 2, 1996
A novel breath actuated device (Autohaler) consistently actuates during the early phase of inspirationP L Marshik, J S Larsen, C L Leach, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 16, 2008
NS11394 [3'-[5-(1-hydroxy-1-methyl-ethyl)-benzoimidazol-1-yl]-biphenyl-2-carbonitrile], a unique subtype-selective GABAA receptor positive allosteric modulator: in vitro actions, pharmacokinetic properties and in vivo anxiolytic efficacyN R Mirza, J S Larsen, C Mathiasen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 19, 2013
Primary tumor location and bevacizumab effectiveness in patients with metastatic colorectal cancerM K Boisen, J S Johansen, C Dehlendorff, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 1, 2023
Deep, rapid, and durable prostate-specific antigen decline with apalutamide plus androgen deprivation therapy is associated with longer survival and improved clinical outcomes in TITAN patients with metastatic castration-sensitive prostate cancerS Chowdhury, A Bjartell, N Agarwal, et al.
Pageof 5

Showing results (41-50 of 50) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 50 results.
The Journal of Asthma : Official Journal of the Association for the Care of Asthma|January 1, 1991
Sensitivity of FEV1 response following one and two inhalations of albuterol: a pilot studyS N Quessy, R J Morris, J S Larsen, et al.
Environmental Science & Technology|March 31, 2006
Impairment of cellular immunity in west Greenland sledge dogs (Canis familiaris) dietary exposed to polluted minke whale (Balaenoptera acutorostrata) blubberChristian Sonne, Rune Dietz, Hans J S Larsen, et al.
Animal : an International Journal of Animal Bioscience|March 27, 2012
Effects of housing conditions during the rearing and laying period on adrenal reactivity, immune response and heterophil to lymphocyte (H/L) ratios in laying hensR O Moe, D Guémené, M Bakken, et al.
Biochemical Pharmacology|December 28, 2014
GABAA α5 subunit-containing receptors do not contribute to reversal of inflammatory-induced spinal sensitization as indicated by the unique selectivity profile of the GABAA receptor allosteric modulator NS16085A Garcia de Lucas, P K Ahring, J S Larsen, et al.
Annals of Allergy|August 1, 1993
Administration errors with a conventional metered dose inhaler versus a novel breath actuated deviceJ S Larsen, M Hahn, J W Kochevar, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 16, 2008
Comparison of the novel subtype-selective GABAA receptor-positive allosteric modulator NS11394 [3'-[5-(1-hydroxy-1-methyl-ethyl)-benzoimidazol-1-yl]-biphenyl-2-carbonitrile] with diazepam, zolpidem, bretazenil, and gaboxadol in rat models of inflammatory and neuropathic painG Munro, J A Lopez-Garcia, I Rivera-Arconada, et al.
Journal of Aerosol Medicine : the Official Journal of the International Society for Aerosols in Medicine|February 2, 1996
A novel breath actuated device (Autohaler) consistently actuates during the early phase of inspirationP L Marshik, J S Larsen, C L Leach, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 16, 2008
NS11394 [3'-[5-(1-hydroxy-1-methyl-ethyl)-benzoimidazol-1-yl]-biphenyl-2-carbonitrile], a unique subtype-selective GABAA receptor positive allosteric modulator: in vitro actions, pharmacokinetic properties and in vivo anxiolytic efficacyN R Mirza, J S Larsen, C Mathiasen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 19, 2013
Primary tumor location and bevacizumab effectiveness in patients with metastatic colorectal cancerM K Boisen, J S Johansen, C Dehlendorff, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 1, 2023
Deep, rapid, and durable prostate-specific antigen decline with apalutamide plus androgen deprivation therapy is associated with longer survival and improved clinical outcomes in TITAN patients with metastatic castration-sensitive prostate cancerS Chowdhury, A Bjartell, N Agarwal, et al.
Pageof 5